Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

DOJ investigating Oak Street Health for possible False Claims Act violations

The Chicago-based chain of 100-plus Medicare clinics said it recently received a civil investigative demand.

Thumbnail

General Electric announces plans to split into 3 separate companies

The firm will divide into organizations focused on healthcare, aviation and energy, GE announced.

States sue Biden over COVID vaccine mandate

President Joe Biden is facing major backlash following a COVID-19 vaccine mandate.

 

Thumbnail

Justice Department charges Arkansas man in $100M COVID scam

An Arkansas man who owned or managed several diagnostic testing laboratories has been indicted on healthcare fraud charges in connection with $100 million in false billings.

 

Biden nominates former Microsoft exec as new CIO of Veterans Affairs

If confirmed, the IT expert would be tasked with leading the VA's estimated $16 billion electronic health record modernization project.

Thumbnail

Andy Slavitt takes over leadership of Cityblock

Andy Slavitt, the former administrator of the Centers for Medicare and Medicaid Services (CMS) under the Obama administration, is temporarily taking over Cityblock Health. 

 

50-something physicians sue former employer for ‘unconscionable’ act of bias

Last February a teaching hospital in the Northeast sacked three pediatric emergency doctors, all in their mid-50s. A handful filed suit, alleging the institution and its parent organization acted primarily out of age discrimination.

Thumbnail

Many nationally recognized cancer centers are not complying with price transparency rules

The lack of cooperation may be hindering efforts to rein in cancer costs and improve affordability, oncology experts explained recently.

Displaying 1617 - 1624 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup